Table 1.
Baseline characteristics and the amount of patients receiving particular antihypertensive monotherapy.
| Parameter | Mean ± SD |
|---|---|
| N | 98 |
| Gender (F/M) | 61/37 |
| Age (year) | 53.6 ± 13.7 |
| BMI (kg/m2) | 33.3 ± 8.7 |
| WHR | 0.9 ± 0.1 |
| Monotherapy | n |
| Diuretic: | 36 |
| Indapamide | 29 |
| Torasemide | 5 |
| Spironolactone | 2 |
| Calcium antagonist | 18 |
| Amlodipine | 13 |
| Nitrendipine | 5 |
| β-blocker | 18 |
| Bisoprolol | 7 |
| Metoprolol | 7 |
| Nebivolol | 4 |
| Angiotensin-converting enzyme inhibitor | 14 |
| Perindopril | 9 |
| Captopril | 3 |
| Ramipril | 2 |
| Angiotensin II receptor antagonist | 12 |
| Losartan | 8 |
| Valsartan | 2 |
| Telmisartan | 2 |
BMI—body mass index; F—female; M—male; n—number of subjects; SD—standard deviation; WHR—waist-hip ratio.